Alyeska Investment Group
AEON icon

Alyeska Investment Group’s AEON Biopharma AEON Stock Holding History

Alyeska Investment Group’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,333
Closed -$2.36M – 408
2022
Q3 		$2.36M Hold
3,333
– – 0.03% 313
2022
Q2 		$2.35M Hold
3,333
– – 0.03% 393
2022
Q1 		$2.35M Buy
+3,333
New +$2.34M 0.03% 404

Other funds holding AEON

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's AEON Position: Q4 2022 in Review

Alyeska Investment Group sold out of AEON Biopharma (AEON) in Q4 2022, closing a stake of 3,333 shares — an estimated $2.36M sold.

Alyeska Investment Group first reported a position in AEON in Q1 2022 and held it in 3 quarters. The position peaked at $2.36M in Q3 2022. 85 funds tracked by Wall St. Rank hold AEON as of Q4 2022.

  • Alyeska Investment Group reported no remaining AEON Biopharma position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 3,333 AEON Biopharma shares in Q4 2022, an estimated $2.36M.
  • Alyeska Investment Group first reported a position in AEON Biopharma in Q1 2022 and held it in 3 quarters.
  • Alyeska Investment Group's AEON Biopharma position peaked at $2.36M in Q3 2022.
  • 85 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.